Brief: Vyne Therapeutics Regains Compliance With Nasdaq Minimum Bid Price Rule
Feb 28 (Reuters) - Vyne Therapeutics Inc VYNE.O :
* VYNE THERAPEUTICS REGAINS COMPLIANCE WITH NASDAQ MINIMUM
BID
PRICE RULE
Source text for Eikon: ID:nGNX44vrxl
Further company coverage: VYNE.O
((Reuters.Briefs@thomsonreuters.com;))